Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Apremilast
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Apremilast 30mg tablets
1001030AAAAAAAA
|
Apremilast | Apremilast | Musculoskeletal and Joint Diseases | 31 |
|
Otezla 30mg tablets
1001030AABBAAAA
|
Otezla | Apremilast | Musculoskeletal and Joint Diseases | 15 |
|
Otezla tablets treatment initiation pack
1001030AABBABAB
|
Otezla | Apremilast | Musculoskeletal and Joint Diseases | 5 |
|
Generic Otezla tablets treatment initiation pack
1001030AAAAABAB
|
Apremilast | Apremilast | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.